Related Experiment Video
Updated: Aug 4, 2026
11:43
Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
Primary pyruvate dehydrogenase E3 binding protein deficiency with mild hyperlactataemia and hyperalaninaemia
I P Hargreaves1, S J R Heales, A Briddon
1Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK. ihargrea@ion.ucl.ac.uk
Journal of Inherited Metabolic Disease
|October 2, 2003
Summary
Pyruvate dehydrogenase E3 binding protein deficiency, a rare metabolic disorder, can cause encephalomyopathy. This case highlights minimal blood lactate and alanine elevation in a 24-year-old male patient.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Pyruvate dehydrogenase E3 binding protein (PDEBP) deficiency is an inherited metabolic disorder affecting the pyruvate dehydrogenase complex.
- This complex plays a crucial role in cellular energy production by converting pyruvate to acetyl-CoA.
- PDEBP deficiency is a rare cause of inherited metabolic encephalomyopathy.
Observation:
- A 24-year-old male presented with symptoms of encephalomyopathy.
- Clinical evaluation revealed only minimal elevations in blood lactate and alanine levels.
- These biochemical findings are atypical for severe mitochondrial disorders.
Findings:
- The case confirms a diagnosis of pyruvate dehydrogenase E3 binding protein deficiency.
- The patient's presentation with minimal metabolic derangement challenges typical diagnostic criteria.
- This suggests variable expressivity or alternative biochemical pathways in PDEBP deficiency.
Implications:
- This case expands the clinical and biochemical spectrum of pyruvate dehydrogenase E3 binding protein deficiency.
- It underscores the importance of considering rare genetic disorders even with subtle biochemical abnormalities.
- Further research is needed to elucidate the full range of PDEBP deficiency phenotypes and genotypes.
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...